ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Auto-immunity"

  • Abstract Number: 3215 • 2015 ACR/ARHP Annual Meeting

    Bim Suppresses the Development of SLE By Limiting Macrophage Inflammatory Responses

    Fu-Nien Tsai1 and Harris R. Perlman2, 1Medicine, Rhuematology, Northwestern University, Chicago, IL, 2Feinberg School of Medicine, Northwestern University, Chicago, IL

    Background/Purpose: The Bcl-2 family guards the mitochondrial apoptotic pathway. Among numerous Bcl-2 antagonists, only the loss of Bim in mice leads to the development of…
  • Abstract Number: 1262 • 2014 ACR/ARHP Annual Meeting

    Mechanisms of Muscular Necrosis in Auto-Immune Myopathies Associated with Anti-Signal Recognition Particle and Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase Antibodies: Pathogenic Role of Auto-Antibodies

    Yves Allenbach1,2,3, Aude Rigolet3, Bruno Eymard4, Tanya Stojkovic4, Anthony. Behin4, Pascal Laforet4, Peter Hufnagl5, Norman Zerbe6, Thierry Maisonobe7, Kuberaka Mariampillai8, Serge Herson8, Olivier Benveniste2,3 and Werner Stenzel9, 1Neuropathology, Charite Hospital, Berlin, Germany, 2UMR 974, Sorbonne Universités, University Pierre et Marie-Curie-Paris 6, INSERM, Paris, France, 3Department: inflammation, immunopathology and biotherapy (DHU i2B), Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France, 4Department of Neurology, Myology Institute, Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière University, Paris, France, 5Pathology departmen, Charite Hospital, Berlin, Germany, 6Department of Pathology, Charite Hospital, Berlin, Germany, 7Neuropathology, Pitie-Salpetriere Hospital, Paris, France, 8Department: inflammation, immunopathology and biotherapy (DHU i2B), Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière University, Paris, France, 9Department of Neuropathology, Charite Hospital, Berlin, Germany

    Background/Purpose: Necrotizing auto-immune myopathies (NAM) are a group of acquired idiopathic inflammatory myopathies characterized by severe muscle weakness and no or mild extra-muscular involvement. Definition of…
  • Abstract Number: 911 • 2014 ACR/ARHP Annual Meeting

    Bioluminescent Imaging of Histidyl-Transfer RNA Synthetase-Induced Myositis Reveals Early-Phase Involvement of NF-Kb-Mediated Inflammation

    Nicholas A. Young1, Lai-Chu Wu1, Michael Bruss2, Wael N. Jarjour3 and Dana P. Ascherman4, 1Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Division of Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 3Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, 4Rheumatology, Miami VAMC, Miami, FL

    Background/Purpose:  The idiopathic inflammatory myopathies represent a group of autoimmune diseases that target muscle as well as extra-muscular organs, leading to significant morbidity and mortality. …
  • Abstract Number: 773 • 2014 ACR/ARHP Annual Meeting

    Functional Autoantibodies from Patients with Systemic Sclerosis Reactive to Angiotensin II Type 1 and Endothelin-1 Type a Receptor Induce Inflammatory Lymphocyte Infiltration into Lungs of Mice

    Angela Kill1, Clement Braesch1, Anja Kühl2, Jeannine Guenther3, Mike O. Becker4, Gerd Burmester5, Thomas Walther6 and Gabriela Riemekasten7, 1Rheumatology and clinical Immunology, Charité University Hospital, German Rheumatology Research Center, a Leibniz Institute, Berlin, Germany, 2Department of Internal Medicine, Charité University Hospital, Berlin, Germany, 3Rheumatology and Clinical Immunology, Charité University Hospital, German Rheumatology Research Center, a Leibniz Institute, Berlin, Germany, 4Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, 5Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany, 6Pharmacology & Therapeutics, University College Cork, Cork, Ireland, 7Charité University Hospital and German Rheumatism Research Centre, a Leibniz Institute, Berlin, Germany

    Background/Purpose Functional autoantibodies reactive to the angiotensin II type 1 receptor (AT1R) and endothelin 1 type A receptor (ETAR) were found in elevated levels in…
  • Abstract Number: 1 • 2014 ACR/ARHP Annual Meeting

    Lymphocyte Proliferation to a Cross-Reactive Gut Commensal Candidate in Antiphospholipid Syndrome

    William Ruff1, Silvio M. Vieira2, Cassyanne Aguiar3,4, John Sterpka2, Andrew Goodman5, Doruk Erkan3,6 and Martin Kriegel1,7, 1Immunobiology, Yale School of Medicine, New Haven, CT, 2Yale School of Medicine, New Haven, CT, 3New York Presbyterian/Weill Cornell Medical Center, New York, NY, 4Pediatric Rheumatology, Hospital for Special Surgery, New York, NY, 5Microbial Pathogenesis, Yale School of Medicine, Microbial Diversity Institute, New Haven, CT, 6Rheumatology, Hospital for Special Surgery, New York, NY, 7Medicine, Section of Rheumatology, Yale School of Medicine, New Haven, CT

    Background/Purpose: Antiphospholipid syndrome (APS) is an autoimmune clotting disorder of unknown etiology targeting a major autoantigen, β2-glycoprotein I (β2GPI). Infectious triggers have been implicated in…
  • Abstract Number: 2730 • 2014 ACR/ARHP Annual Meeting

    FcγRIIIa Ligation in Human Peripheral CD4+ T-Cells Generate TH17 like Population

    Anil K. Chauhan1, Terry Moore2 and Chen Chen3, 1Rheumatology, Saint Louis University, St. Louis, MO, 2Rheumatology/Immunology, St Louis University, Saint Louis, MO, 3Rheumatology/Internal Medicine, Saint Louis University, St. Louis, MO

    Background/Purpose: Cytokines produced during TH17 response, IL-17A and IL17F drive inflammation and autoimmunity. They also act as a bridge between adaptive and innate immunity. Immune…
  • Abstract Number: 2687 • 2014 ACR/ARHP Annual Meeting

    Estrogen-Mediated STAT1 Activation By Estrogen Receptor a Induces TLR8 Expression: A Novel Pathogenic Mechanism in Systemic Lupus Erythematosus

    Nicholas Young1, Giancarlo Valiente2, Lai-Chu Wu3, Michael Bruss4, Stacy Ardoin2, Craig Burd5 and Wael N. Jarjour6, 1Ohio State University, Columbus, OH, 2Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 3Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 4Division of Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 5Molecular & Cellular Biochemistry, The Ohio State University, Columbus, OH, 6Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: Many autoimmune disorders, including Systemic Lupus Erythematosus (SLE) display female gender predominance.  Previous studies have demonstrated significant hormonal contributions to SLE pathogenesis, including estrogen,…
  • Abstract Number: 2686 • 2014 ACR/ARHP Annual Meeting

    Gene Array Analysis Reveals Unique Estrogen Signature in Peripheral Blood Mononuclear Cells of Patients with Systemic Lupus Erythematosus

    Stephanie Amici1, Nicholas A. Young2, Lai-Chu Wu2, Mireia Guerau1 and Wael N. Jarjour3, 1Health and Rehab Sciences, The Ohio State University, Columbus, OH, 2Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 3Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune disorder predominately affecting females in the reproductive age range.  Estrogen is present at higher levels in this…
  • Abstract Number: 2530 • 2014 ACR/ARHP Annual Meeting

    PRE.MARK-TNF Test Based on Iga-Specific Autoantigens Predicts Therapy Response in Rheumatoid Arthritis Patients Treated with TNFα Inhibitors

    Karl Skriner1, Jörg Hollidt2, Gerd Burmester3 and Zoltan Konthur4, 1Department of Rheumatology and Clinical Immunology, Germany, Charité - Universitätsmedizin Berlin, Berlin, Germany, 2Drug Response DX GmbH, Berlin, Germany, 3Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany, 4Drug Response DX GmbH, Hennigsdorf, Germany

    Background/Purpose One third of rheumatoid arthritis patients treated with biologicals targeting TNFα are therapy non-responders. We have earlier investigated the difference in seroreactivity of patients…
  • Abstract Number: 2219 • 2014 ACR/ARHP Annual Meeting

    Contribution of Tripartite Motif Proteins Modulating Membrane Repair to the Pathogenesis of Autoimmune-Mediated Myositis

    Jenna Alloush1, Nicholas A. Young2, Kevin McElhanon1, Wael N. Jarjour3 and Noah Weisleder1, 1Department of Physiology and Cell Biology, Davis Heart and Lung Research Institute, The Ohio State University College of Medicine, Columbus, OH, 2Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 3Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: The idiopathic inflammatory myopathies are a heterogeneous group of diseases that result in autoimmunity toward muscles and lead to tissue destruction, but the pathogenesis…
  • Abstract Number: 2186 • 2014 ACR/ARHP Annual Meeting

    Clinical and Immunologic Correlates in Cocaine Users with Serum Anti-Neutrophil Cytoplasmic Antibodies

    Christian Lood and Grant C. Hughes, Medicine/Rheumatology, University of Washington, Seattle, WA

    Background/Purpose: Illicit cocaine use is associated with the development of serum anti-neutrophil cytoplasmic autoantibodies (ANCA) and a variety of clinical manifestations. However, the mechanisms linking…
  • Abstract Number: 2162 • 2014 ACR/ARHP Annual Meeting

    Immunological Abnormalities in Adult Patients with Parvovirus B19 Infection : A study of 23 Cases

    Edouard Pertuiset, Farid Kemiche, Mehdi Yahia and Isabelle Cerf-Payrastre, Rheumatology, Centre Hospitalier René Dubos, Pontoise, France

    Background/Purpose In adults, parvovirus B19 infection can induce joint symptoms and cutaneous manifestations which are known to be transient most of the time. It has…
  • Abstract Number: 1472 • 2014 ACR/ARHP Annual Meeting

    Synovial Fluid from Rheumatoid Arthritis Patients Modulates the Immunophenotype and Viability of Monocytes

    Maria Sole Chimenti, Alberto Bergamini, Eleonora Baffari, Eleonora Ballanti, Alessia Musto, Paola Conigliaro and Roberto Perricone, Rheumatology, allergology and clinical immunology, Department of "Medicina dei Sistemi", University of Rome "Tor Vergata", Rome, Italy

    Background/Purpose Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by infiltration of the synovium by inflammatory cells that destroys the cartilage and the…
  • Abstract Number: 1902 • 2013 ACR/ARHP Annual Meeting

    Characterization Of HLA-DRB1 Distribution By 3rd Hypervariable Region Sequence In Systemic Sclerosis and Control Populations

    Coline, A. Gentil1, Hilary S. Gammill1, Christine, T. Luu1 and J. Lee Nelson2, 1Immunogenetics, Fred Hutchinson Cancer Research Center, SEATTLE, WA, 2Immunogenetics D2-100, Fred Hutchinson Cancer Rsch, Seattle, WA

    Background/Purpose: HLA class II genes are associated with a wide spectrum of autoimmune diseases.  Specific alleles at the DRB1, DQA1 and DQB1 loci are associated…
  • Abstract Number: 1792 • 2013 ACR/ARHP Annual Meeting

    Inhibition Of Chemokine Receptors CCR1 and CCR6 As Promising Therapies For Autoimmune Diseases Such As Rheumatoid Arthritis and Psoriasis

    Daniel Dairaghi1, Penglie Zhang2, Manmohan Leleti2, Robert Berahovich3, Karen Ebsworth3, Linda Ertl3, Shichang Miao4, Zhenhua Miao3, Lisa Seitz3, Joanne Tan3, Matthew Walters3, Yu Wang3, Jay Powers5, Thomas J. Schall6 and Juan C. Jaen7, 1Biology, ChemoCentryx, Inc., Mountain View, CA, 2Chemistry, ChemoCentryx, Mountain View, CA, 3Biology, ChemoCentryx, Mountain View, CA, 4Pharmacokinetics, ChemoCentryx, Inc., Mountain View, CA, 5ChemoCentryx, Mountain View, CA, 6ChemoCentryx, Inc., Mountain View, CA, 7Discovery and Preclinical Development, ChemoCentryx, Inc., Mountain View, CA

    Background/Purpose:  Chemokines are key regulators of leukocyte activation and recruitment to sites of inflammation. Of particular relevance in rheumatoid arthritis (RA), the chemokine receptors CCR1…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology